세계의 의약품 수탁 포장 시장 보고서(2025년)
Pharmaceutical Contract Packaging Global Market Report 2025
상품코드 : 1818579
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의약품 수탁 포장 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.4%로 471억 2,000만 달러에 달할 전망입니다. 예측 기간의 성장은 지속 가능한 포장에 대한 관심 증가, 주문형 포장 서비스에 대한 수요, 맞춤형 및 개인화 추세, 어린이 보호 포장에 대한 수요, 포장 인프라에 대한 전략적 투자에 기인합니다. 예측 기간 동안 선진 패키징 트렌드에는 시리얼라이제이션 및 추적 컴플라이언스, 포장 장비의 기술 발전, 콜드체인 패키징의 전문화, 환자 컴플라이언스를 위한 준수 패키징, 개인화된 의료용 패키징, 디지털화 투자, 인더스트리 4.0 등이 포함됩니다. 등이 포함됩니다.

향후 5년간 8.4%의 성장률 전망은 지난번 예측보다 0.3% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 이는 이탈리아, 스위스, 인도 등 주요 지역에서 조달되는 블리스 터 포장 호일, 변조 방지 캡 등 핵심 부품공급망 혼란을 통해 미국에 직접적으로 영향을 미칠 가능성이 높으며, 의약품 유통 지연으로 이어질 수 있습니다. 또한, 상호 관세와 무역 마찰 및 제한 강화로 인한 세계 경제 및 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

고령인구 증가는 향후 의약품 위탁포장 시장의 성장을 견인할 것으로 예측됩니다. 노인이란 65세 이상의 인구를 말합니다. 이 인구층이 증가함에 따라 제조업체는 노인도 쉽게 열 수 있고 어린이도 사용할 수 있는 패키지를 만들어야 하며, 이는 비용 상승과 지속가능성에 영향을 미칠 수 있습니다. 예를 들어, 스위스에 본부를 둔 보건기구인 세계보건기구(WHO)는 2024년 10월, 60세 이상 세계 인구가 2020년 10억 명에서 2030년까지 14억 명으로 크게 증가하여 2050년까지 21억 명에 달할 것으로 예측했습니다. 또한, 80세 이상 인구는 3배 증가하여 2050년에는 4억 2,600만 명에 달할 것으로 예측됩니다. 따라서 노인 인구 증가가 의약품 위탁포장 시장의 확대를 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나19와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Pharmaceutical contract packaging serves as a cost-efficient method for ensuring the presentation, protection, identification, convenience, compliance, integrity, and stability of products. It plays a pivotal role in product identification and shielding against potential contamination, thus significantly contributing to product safety and integrity.

The primary components of pharmaceutical contract packaging encompass primary, secondary, and tertiary packaging. Primary packaging directly interacts with the product and is often known as consumer or retail packaging. Utilizing materials like paper, paperboard, plastics, polymers, aluminum foil, glass, and other substances, primary packaging caters to small molecules, biopharmaceuticals, and vaccines, playing a crucial role in preserving and presenting pharmaceutical products.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and rising trade tensions in spring 2025 are having a substantial impact on the machinery sector, driving up the costs of essential components such as steel, hydraulic systems, and precision bearings many of which are sourced from regions affected by the tariffs. Manufacturers of construction, agricultural, and industrial machinery are now facing tighter profit margins, as existing long-term contracts limit their ability to raise prices immediately. This climate of uncertainty has also led to postponed investments in automation and smart machinery, slowing potential productivity improvements. In response, companies are focusing on developing local suppliers, redesigning products to incorporate alternative materials, and adopting predictive maintenance strategies to extend equipment life and reduce the need for costly replacements.

The pharmaceutical contract packaging market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical contract packaging market statistics, including pharmaceutical contract packaging industry global market size, regional shares, competitors with a pharmaceutical contract packaging market share, detailed pharmaceutical contract packaging market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract packaging industry. This pharmaceutical contract packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical contract packaging market size has grown strongly in recent years. It will grow from $31.67 billion in 2024 to $34.1 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing complexity of packaging regulations, need for rapid time-to-market, demand for specialized packaging solutions, globalization of pharmaceutical supply chains, cost savings and operational efficiency, flexibility in production scale.

The pharmaceutical contract packaging market size is expected to see strong growth in the next few years. It will grow to $47.12 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increased focus on sustainable packaging, demand for on-demand packaging services, customization and personalization trends, demand for child-resistant packaging, strategic investments in packaging infrastructure. Major trends in the forecast period include serialization and track-and-trace compliance, technological advancements in packaging equipment, specialization in cold chain packaging, adherence packaging for patient compliance, personalized medicine packaging, investments in digitalization and industry 4.0.

The forecast of 8.4% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for critical components like blister packaging foils and tamper-evident caps, sourced from key regions such as Italy, Switzerland, and India, which could lead to delays in medication distribution. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing number of elderly individuals is anticipated to drive the growth of the pharmaceutical contract packaging market in the future. The elderly population refers to those aged 65 and older. As this demographic grows, manufacturers are being compelled to create packaging that is easier for seniors to open while still being child-resistant, which can lead to higher costs and impact sustainability. For example, in October 2024, the World Health Organization, a health agency based in Switzerland, reported that the global population aged 60 years and above is projected to rise significantly from 1 billion in 2020 to 1.4 billion by 2030, ultimately reaching 2.1 billion by 2050. Additionally, the number of individuals aged 80 years or older is expected to triple, reaching 426 million by 2050. Therefore, the growth in the elderly population is driving the expansion of the pharmaceutical contract packaging market.

The trend of globalization is expected to have a significant impact on the growth trajectory of the pharmaceutical contract packaging market. Globalization refers to the interconnectedness of various elements among countries, including economic, cultural, and technological exchanges. In the pharmaceutical sector, this trend necessitates standardized packaging solutions that comply with different international regulations. Contract packaging providers are essential in modifying pharmaceutical packaging to align with regional requirements and quality standards as global pharmaceutical supply chains expand. For instance, in April 2023, a report from the World Bank, a US-based international organization, indicated that around 56% of the global population, or 4.4 billion people, currently lives in cities. This trend is anticipated to continue, with the urban population expected to more than double by 2050, when nearly 70% of individuals will reside in urban areas. Therefore, globalization serves as a driving force in the pharmaceutical contract packaging market.

Technological innovation is a significant trend gaining traction in the pharmaceutical contract packaging market. Key players in this industry are focusing on developing new technological advancements to enhance their market presence. For example, in November 2022, Gerresheimer AG, a Germany-based company specializing in drug delivery systems, and Stevanato Group, an Italy-based provider of drug containment, delivery, and diagnostic solutions, introduced EZ-fill Smart. This technology ensures seamless integration with standard fill and finish operations and is suitable for both small and large batch production. The EZ-fill Smart solution aims to enhance drug packaging quality, lower total cost of ownership (TCO), and reduce lead times for customers while implementing a new eco-friendly sterilization method and utilizing biopolymers and recycled plastics.

Leading companies are forming collaborations and partnerships to solidify their position in the pharmaceutical contract packaging market. A strategic partnership is a structured association between two or more commercial entities, typically formalized through one or more business agreements or contracts. For instance, in July 2022, West Pharmaceutical Services, a US-based provider of innovative injectable drug packaging solutions, teamed up with Corning, a US-based glass innovation company, to deliver advanced packaging solutions for injectable drugs by merging Corning's glass innovations with West's packaging technology expertise. This collaboration aims to enhance packaging capabilities for high-value biologics and specialty pharmaceuticals, ensuring global safety, efficacy, and regulatory compliance for injectable therapies.

In February 2022, Recipharm, a leading contract development and manufacturing organization (CDMO) based in Sweden, acquired Arranta Bio for an undisclosed sum. This acquisition is intended to enhance Recipharm's biologics capabilities, which include production services for innovative drug therapies and packaging solutions for pharmaceutical products. This strategic move is viewed as a way to strengthen their service offerings in response to the increasing global demand for contract pharmaceutical packaging and biopharma services. Arranta Bio is a US-based contract development and manufacturing company that specializes in advanced therapy medicinal products (ATMPs).

Major companies operating in the pharmaceutical contract packaging market are Nipro Corporation, Daito Pharmaceutical Co Ltd., Pfizer CentreOne, Catalent Inc., WestRock Company, BALL CORPORATION, Berlin Packaging, CCL Industries Inc., Co-Pak Packaging Corporation, Signode India Limited, Ropack Pharma Solutions, Reelvision Print Limited, PCI Pharma Services, Multi-Pack Solutions LLC, Unicep Packaging Inc, Reed-Lane Inc., Aphena Pharma Solutions Holdings Inc., Southwest Packaging and Supply Corporation, AbbVie Inc., Almac Group Limited, AmeriPac Inc, Assemblies Unlimited Inc., CentralPharma, DaklaPack Filling & Packaging, DelobrisPharmaceuticals Limited, Elitefill Inc., Finishing Services Inc., Jones Packaging Inc., LABO S.R.L., MJS Packaging Inc., MPH Co-Packing LLC, Nelipak B.V., Pharma Packaging Solutions LLC, Sepha Limited, SternMaid GmbH

North America was the largest region in the pharmaceutical contract packaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the pharmaceutical contract packaging market report during the forecast period. The regions covered in the pharmaceutical contract packaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical contract packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical contract packaging market includes revenues earned by entities in different categories, such as drug labelling and packaging. The services provided by a contract pharmaceutical packager include designing medicine packaging and testing the packed drug. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Contract Packaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical contract packaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for pharmaceutical contract packaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical contract packaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Pharmaceutical Contract Packaging Market Characteristics

3. Pharmaceutical Contract Packaging Market Trends And Strategies

4. Pharmaceutical Contract Packaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Contract Packaging Growth Analysis And Strategic Analysis Framework

6. Pharmaceutical Contract Packaging Market Segmentation

7. Pharmaceutical Contract Packaging Market Regional And Country Analysis

8. Asia-Pacific Pharmaceutical Contract Packaging Market

9. China Pharmaceutical Contract Packaging Market

10. India Pharmaceutical Contract Packaging Market

11. Japan Pharmaceutical Contract Packaging Market

12. Australia Pharmaceutical Contract Packaging Market

13. Indonesia Pharmaceutical Contract Packaging Market

14. South Korea Pharmaceutical Contract Packaging Market

15. Western Europe Pharmaceutical Contract Packaging Market

16. UK Pharmaceutical Contract Packaging Market

17. Germany Pharmaceutical Contract Packaging Market

18. France Pharmaceutical Contract Packaging Market

19. Italy Pharmaceutical Contract Packaging Market

20. Spain Pharmaceutical Contract Packaging Market

21. Eastern Europe Pharmaceutical Contract Packaging Market

22. Russia Pharmaceutical Contract Packaging Market

23. North America Pharmaceutical Contract Packaging Market

24. USA Pharmaceutical Contract Packaging Market

25. Canada Pharmaceutical Contract Packaging Market

26. South America Pharmaceutical Contract Packaging Market

27. Brazil Pharmaceutical Contract Packaging Market

28. Middle East Pharmaceutical Contract Packaging Market

29. Africa Pharmaceutical Contract Packaging Market

30. Pharmaceutical Contract Packaging Market Competitive Landscape And Company Profiles

31. Pharmaceutical Contract Packaging Market Other Major And Innovative Companies

32. Global Pharmaceutical Contract Packaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Contract Packaging Market

34. Recent Developments In The Pharmaceutical Contract Packaging Market

35. Pharmaceutical Contract Packaging Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기